ACADIA Pharmaceuticals, Inc. (ACAD)
21.23
-0.01
(-0.05%)
USD |
NASDAQ |
Nov 06, 16:00
21.21
-0.02
(-0.09%)
After-Hours: 20:00
ACADIA Pharmaceuticals Total Long Term Debt (Quarterly) : 57.32M for Sept. 30, 2026
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 57.32M |
| June 30, 2026 | 59.55M |
| March 31, 2026 | 39.00M |
| December 31, 2025 | 40.55M |
| September 30, 2025 | 43.03M |
| June 30, 2025 | 44.60M |
| March 31, 2025 | 44.63M |
| December 31, 2024 | 42.04M |
| September 30, 2024 | 40.42M |
| June 30, 2024 | 47.19M |
| March 31, 2024 | 49.19M |
| December 31, 2023 | 47.80M |
| September 30, 2023 | 48.10M |
| June 30, 2023 | 49.78M |
| March 31, 2023 | 51.44M |
| December 31, 2022 | 52.70M |
| September 30, 2022 | 53.77M |
| June 30, 2022 | 54.69M |
| March 31, 2022 | 55.48M |
| December 31, 2021 | 56.13M |
| September 30, 2021 | 57.68M |
| June 30, 2021 | 59.13M |
| March 31, 2021 | 60.58M |
| December 31, 2020 | 44.46M |
| September 30, 2020 | 45.34M |
| Date | Value |
|---|---|
| June 30, 2020 | 5.669M |
| March 31, 2020 | 6.09M |
| December 31, 2019 | 6.361M |
| September 30, 2019 | 6.379M |
| June 30, 2019 | 6.742M |
| March 31, 2019 | 6.754M |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Ionis Pharmaceuticals, Inc. | 2.189B |
| Arcturus Therapeutics Holdings, Inc. | 18.24M |
| ADMA Biologics, Inc. | 201.62M |
| Immunic, Inc. | 0.328M |
| Viking Therapeutics, Inc. | 254.67M |